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ABSTRACT 20	  
The number of peripheral blood B lymphocytes doubles during acute exercise, but the phenotypic composition of this 21	  
response remains unknown. In two independent exercise studies, using complimentary phenotyping strategies, we 22	  
2	  
	  
investigated the mobilisation patterns of distinct B cell subsets. In study one, nine healthy males (mean ± SD age:  23	  
22.1 ± 3.4 years) completed a continuous cycling bout at 80% MAX for 20 mins. In study two, seven healthy 24	  
experienced cyclists (mean ± SD age:  29.9 ± 4.7 years) completed a 30 min cycling trial at a workload corresponding 25	  
to +5% of the individual blood lactate threshold. In study one, CD3−CD19+ B cell subsets were classified into 26	  
immature (CD27−CD10+), naïve (CD27−CD10−), memory (CD27+CD38−), plasma cells / plasmablasts 27	  
(CD27+CD38+) and finally, recently purported ‘B1’ cells (CD27+CD43+CD69−). In study two, CD20+ B cells were 28	  
classified into immature (CD27−IgD−), naïve (CD27−IgD+), and IgM+/IgG+/IgA+ memory cells (CD27+IgD−). 29	  
Total B cells exhibited a mean increase of 88% (study one) and 60% (study two) during exercise. In both studies, 30	  
immature cells displayed the greatest increase, followed by memory cells, then naïve cells (study one: immature 130% 31	  
> mature 105% > naïve 84%; study two: immature 110% > mature 56% > naïve 38%). Our findings show that, unlike 32	  
T cells and NK cells, B cell mobilisation is not driven by effector status, and, for the first time, that B cell mobilisation 33	  
during exercise is comprised of immature CD27− IgD−/CD10+ cells. 34	  
 35	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 37	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1. INTRODUCTION 39	  
Acute exercise causes a profound, rapid and transient change to the cellular composition of blood. 40	  
Lymphocyte numbers increase markedly, falling below resting levels shortly after exercise cessation, and then 41	  
returning to pre-exercise levels a few hours later (47). The primary mechanism for this effect is the expression of β2-42	  
adrenergic receptors on the surface of lymphocytes (10), that, in response to exercise-induced elevations in 43	  
catecholamine levels, induce lymphocyte detachment from the vascular endothelium and subsequent lymphocyte 44	  
release into the peripheral bloodstream (2, 34). The most exercise-responsive lymphocyte populations (with the 45	  
highest β2-adrenergic receptor expression density) are natural killer (NK) cells and effector memory CD8+ T cells (3, 46	  
4, 43). These populations are capable of mounting rapid effector functions that may bolster immune competence (3). 47	  
Like their lymphoid counterparts, B cells also express β2-adrenergic receptors (26, 39) and show marked mobilisation 48	  
responses during exercise, for example increasing by 100% in response to an acute (24 min) bout of intensive cycling 49	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at 85% Wmax (4). However, changes to the phenotypic composition of peripheral blood B cells during exercise has not 50	  
been well characterised, and it remains unknown whether B cells with a capacity to mount rapid effector functions are 51	  
preferentially mobilised by exercise (i.e., in a parallel fashion to effector T cell and NK cells). Such effects would lend 52	  
support to the theory that exercise causes a global priming of the immune system whereby leukocytes with an effector 53	  
phenotype are mobilised into the bloodstream to enable their migration to sites of injury and subsequent antigenic 54	  
challenge (7, 8).  55	  
Prior research using a rodent model of acute stress may lend support to this theory. Indeed, it was purported 56	  
that class-switched B cells (i.e., memory cells) are more sensitive to stress than their naïve counterparts, and may be 57	  
redeployed to peripheral sites post-stress to screen for, and facilitate responses to, cognate antigen (8). Using CD62L 58	  
(L-selectin) as a marker to differentiate naïve B cells (CD62L+) from memory B cells (CD62L−), it was shown that 59	  
CD62L− B cells trafficked to a greater extent than CD62L+ B cells during acute stress (8). Although loss of CD62L 60	  
on B cells is not an exclusive indicator of memory status or homing capacity to peripheral sites (33, 37), CD62L− cells 61	  
have been shown to predominate skin sites, thus giving some support to the hypothesis that these cells are mobilised to 62	  
sites of potential injury or infection (17, 49). To date, in-depth phenotyping of B cell subset changes in response to 63	  
acute exercise or stress has not been conducted. However, it has been shown that some humoral processes with B cell 64	  
lineage involvement, such as immunoglobulin (20) and free light chain synthesis (23), are impacted by regular 65	  
exercise in humans. Thus, perturbations in these parameters, that are likely to be influenced by the phenotype of cells 66	  
present in the bloodstream or tissues, may have consequences for health via changes to immune competency or 67	  
reduced low-grade inflammation (23). It is therefore important to characterise how a single bout of exercise impacts B 68	  
cell sub-type re-distribution in humans. 69	  
Thus, in this work we investigated the mobilisation of distinct B cell subsets in two independent acute 70	  
exercise studies. In both exercise studies we used the cell surface marker CD27 to differentiate naïve from antigen 71	  
experienced B cells. CD27 is a disulphide linked homodimeric glycoprotein involved in T cell activation and B cell 72	  
regulation that is expressed by memory B cells, but not by naïve cells (1, 29, 30), and is considered the most reliable 73	  
backbone marker for delineating memory status of B cells (29). In addition, CD27 can be used in combination with 74	  
other markers to identify distinct B cell subpopulations and a number of different approaches have been proposed to 75	  
fulfil this purpose (1, 29). In this investigation, we used two common approaches to differentiate immature B cells 76	  
from naïve B cells: analysis of CD10 expression (5, 41), and analysis of IgD expression (25, 35). In addition, we used 77	  
CD38 to differentiate plasmablasts / plasma cells from memory cells (5). We also investigated exercise-induced 78	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mobilisation of a recently purported ‘B1’ cell population, identified as CD27+CD43+CD69− (21). B1 cells represent a 79	  
large B cell population whose primary characteristic is the production of low-affinity natural antibody that is broadly 80	  
avid against invading pathogens; an exercise-induced mobilisation of these cells might be a beneficial adaptation that 81	  
helps ward off infections during times of stress or physiological strain, as part of the “fight or flight” response. In the 82	  
present study, we hypothesised that acute exercise would result in a greater mobilisation of effector B cells (i.e., 83	  
memory and B1 cells) compared to naïve and immature B cells (8). 84	  
 85	  
2. MATERIAL AND METHODS 86	  
2.1 Participants 87	  
Data for this investigation was collected from two independent exercise studies: study one was conducted in 88	  
the School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, UK and study two was 89	  
conducted in the Department of Health and Human Performance, University of Houston, Texas, USA.  90	  
In study one, peripheral blood mononuclear cells (PBMCs) were collected from nine participants (age: 22.1 ± 91	  
3.4 years; height: 180.5 ± 6.1 cm; weight: 78.1 ± 11.0 kg; body mass index: 24.0 ± 3.1 kg.m2; MAX: 43.8 ± 4.1 92	  
ml.kg.min−1) as previously described (44-46). All participants were non-smokers, and refrained from taking vitamin 93	  
supplements and anti-inflammatory medication for fourteen days, and did not exercise and consume alcohol of 94	  
caffeine for two days prior to testing. Participants also fasted overnight prior to the main exercise trial. All participants 95	  
provided written consent and the study was approved by the Science, Technology, Engineering and Mathematics 96	  
Ethical Review Committee at University of Birmingham.  97	  
In study two, PBMCs were collected from seven healthy males (age: 29.9 ± 4.7 years; height: 175.4 ± 10.9 98	  
cm; weight: 70.0 ± 7.9 kg; body mass index: 22.8 ± 1.8 kg.m2; +5% LT: 47.6 ± 10.1 ml.kg.min−1) as previously 99	  
described (27). All participants were experienced cyclists, non-smokers, not taking medication or supplements 100	  
affecting the immune system and were free from any infectious illness for 6-weeks prior to testing. Participants were 101	  
asked to fast overnight and refrain from exercise 24 hours prior to testing. After receiving oral and written information 102	  
pertaining to the risks and demands of the study, each participant signed an informed consent document and the study 103	  
was approved by the committee for the protection of human subjects at the University of Houston. 104	  
2.2 Preliminary measurements 105	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 For both studies, height and weight were assessed using standard methods. For study one, cardiorespiratory 106	  
fitness ( MAX) was measured using an incremental test to exhaustion on an electromagnetically braked cycle 107	  
ergometer (Lode Excalibur Sport, Groningen, Netherlands). A facemask was fitted throughout the exercise test, and 108	  
expired air was assessed for oxygen uptake and carbon dioxide production, averaged every 20 seconds, from breath-109	  
by-breath samples (Oxycon Pro, Jaeger, Wuerzberg, Germany). Heart rate (HR) was monitored every minute using a 110	  
Polar Vantage heart rate monitor (Polar Vantage, Kempele, Finland); maximal heart rate represents the maximum 111	  
heart rate achieved during the trial. Following a three-minute warm up at 30 watts, workload was increased by 30 112	  
watts every minute, until volitional exhaustion. The following criteria were used to indicate that MAX had been 113	  
reached: a fall in cadence below 60 rpm, a respiratory exchange ratio ( / ) >1.10-1.15, plateau in participant 114	  
oxygen consumption or a maximal heart rate >220 beats min-1 – age.  115	  
For study two, participants attended the laboratory to conduct an initial incremental discontinuous cycling test 116	  
to determine individual blood lactate threshold (BLT). The initial BLT and subsequent exercise trial were conducted 117	  
on participants’ personal road bicycles mounted to an indoor cycle ergometer (Computrainer Lab, Racermate, Inc., 118	  
Seattle, WA). Prior to the BLT, resting capillary blood samples were collected from the earlobe to determine resting 119	  
blood lactate concentration. All blood lactate concentrations were determined immediately in duplicate using an 120	  
automated pre-calibrated analyser (P-GM7 MicroStat, Analox Instruments, London, UK). After a 10 min warm-up 121	  
consisting of cycling against no resistance, participants began the protocol which consisted of 3 min incremental 122	  
stages. Initial starting workload increments were dependent on participant fitness levels and ranged from 50 – 100 W 123	  
and increments of 20 – 25 W. Participants were instructed to maintain steady, comfortable revolutions per minute 124	  
(RPM) throughout the test. Heart rate and breath-by-breath metabolic data ( , , ventilation and respiratory 125	  
exchange ratio) were measured continuously using a metabolic cart (Quark CPET, Cosmed, Rome, Italy). The test was 126	  
terminated one incremental stage after attaining a blood lactate concentration of >4 mM. The power output 127	  
corresponding to the BLT was determined individually using the breakpoint method defined by Weltman (1995). In 128	  
brief, blood lactate concentration (mM) was plotted against power (watts), with the threshold being determined as the 129	  
power output corresponding to the break-point where a curvilinear rise in blood lactate concentration is first observed 130	  
(48). For both studies, a rating of perceived exertion (RPE) was recorded using the Borg scale at each stage. 131	  
 132	  
2.3 Experimental trials 133	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 For both studies, experimental trials were undertaken at least two days after the preliminary tests and were 134	  
scheduled at a similar time of day. Prior to the exercise trial in study one, participants completed a warm up (5 min) at 135	  
a workload eliciting 40% MAX, before undertaking the steady state cycling task at 80% MAX for 20 minutes. A 136	  
facemask was fitted throughout exercise for breath-by-breath measurements. Workload was expressed as watts, and 137	  
relative to body mass (i.e., watts/kg). Values presented are the average workload over the entire exercise protocol and 138	  
were obtained directly from the electromagnetically braked cycle ergometer (Lode Excalibur Sport, Groningen, 139	  
Netherlands). Ratings of perceived exertion (RPE) were recorded using the Borg Scale every minute and RPE results 140	  
are presented as the maximal RPE during the trial (44-46). In study two, participants completed a 30 min exercise trial 141	  
at a workload corresponding to +5% of the individual blood lactate threshold. Following a 10 min warm-up, 142	  
participants were instructed to cycle at the same cadence maintained during the BLT test; RPM was monitored and 143	  
recorded every 5 min. Capillary blood samples were collected from the earlobe every 10 min for the analysis of blood 144	  
lactate. In both studies, heart rate was measured every minute, and data were expressed as a percentage of age-145	  
predicted maximum heart rate using average heart rate and the equation 191.5−0.007 × age2 (18).   146	  
 147	  
2.4 Blood sampling, cell isolation and flow cytometry 148	  
For both studies, blood samples were drawn into potassium ethylene diaminetetraacetic acid (EDTA) 149	  
vacutainer tubes (Becton & Dickson, Oxford, UK) after thirty minutes of rest, during the final minute of exercise, and 150	  
thirty minutes later (study one) or 60 minutes later (study two).  151	  
In study one, blood from each time point was diluted 1:1 with Roswell Park Memorial Institute media 152	  
(RMPI), and layered on top of Ficoll paque PLUS (GE Healthcare) (2:1), before centrifuging at 500 × g for 30 153	  
minutes at 21°C.  PBMCs were aspirated and washed three times in RPMI by centrifuging at 400 × g for 5 minutes. 154	  
The cell pellet was re-suspended in 1-millitre of freezing mixture (70% RPMI, 20% fetal calf serum (FCS) and 10% 155	  
dimethyl sulfoxide (DMSO)) and frozen at −1°C /min using a freezing container (Nalgene “Mr Frosty” 156	  
Thermoscientific). Cells were stored at −80°C and analysed within six months. For analysis, PBMCs were thawed 157	  
rapidly at 37°C and washed twice in phosphate buffered saline (PBS) containing 2% FCS and 2mM EDTA (MACS 158	  
buffer) by centrifuging at 400 × g for 5 minutes. Cells were counted using a haemocytometer and approximately 159	  
300,000 PBMCs were added to tubes for incubation with fluorescently conjugated antibodies. Specific lymphocyte 160	  
populations were identified by immunofluorescent monoclonal antibody (mAb) staining of whole blood by eight-161	  
colour flow cytometry (FACS-CANTO II, Becton–Dickinson, San Jose, USA). The following mAbs were used to 162	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stain cells using vendor-recommended concentrations: anti-CD3-V450 clone #UCHT1, anti-CD19-V500 clone 163	  
#HIB19 (BD Horizon, San Diego, USA), anti-CD27-APC clone #M-T271, anti-CD43-FITC clone #IG10, anti-CD69-164	  
PE clone #FN50 (BD Pharmingen, San Diego, USA), anti-CD10-APC-Cy7 clone #HI10a, and anti-CD38-PE-Cy7 165	  
clone #HIT2 (BioLegend, San Diego, USA). Using these mAbs, CD3−CD19+ B cell subsets were classified into 166	  
immature (CD27−CD10+), naïve (CD27−CD10−), memory (CD27+CD38−), plasma cells / plasmablasts 167	  
(CD27+CD38+) (5), as well as recently purported ‘B1’ cells (CD27+CD43+CD69−) (21) (Table 1). 7-168	  
aminoactinomycin D (7-AAD; PerCP channel; BD Pharmingen, San Diego, USA) was used to exclude apoptotic and 169	  
necrotic cells. FSC-area versus FSC-height was used for doublet discrimination. Flow cytometry analyses were 170	  
conducted using FlowJo version 7.6.5 (FlowJo LLC, Oregon, USA). The total leukocyte count was assessed using an 171	  
automated haematology analyser (Coulter Analyser, Beckman-Coulter, High Wycombe, UK). 172	  
In study two, PBMCs were separated from whole blood using almost identical methodology to study one, 173	  
except blood was diluted and cells were washed in PBS. In addition, approximately 1,000,000 fresh PBMCs were 174	  
stained in MACS buffer with the following fluorescently labelled mAbs using vendor-recommended concentrations: 175	  
anti-CD20-PerCP clone #L27 (BD Biosciences, San Diego CA USA), anti-IgD-PE clone #IA6-2, Anti-IgM-PE clone 176	  
#G20-127 (BD Pharmingen, San Diego CA USA), anti-IgA1-PE clone #B3506B4, anti-IgG-PE clone #H2 (Southern 177	  
Biotech, Birmingham AL USA) and anti-CD27-FITC clone #0323 (eBioscience, San Diego CA USA). Using these 178	  
mAbs, CD20+ B cells were classified into immature (CD27−IgD−), naïve / transitional (CD27−IgD+), and 179	  
IgG+/IgA+ class switched memory cells (CD27+IgD−) (30, 40) (Table 1). Cellular analyses were conducted on a BD 180	  
Accuri C6 (Becton Dickinson San Jose CA USA) flow cytometer, as previously described (42). Flow cytometry data 181	  
analyses were conducted on CFlow® Software (CFlow® software V2). Total leukocyte count was quantified on a flow 182	  
cytometer by mixing whole blood with a red cell lysing buffer (eBioscience, San Diego CA USA) for 15 min and the 183	  
number of gated lymphocytes counted in 40µl of lysed blood at a flow rate of 14µl/min was determined and then 184	  
adjusted by the dilution factor. This flow cytometry-based technique was internally validated using a clinical 185	  
haematology analyser (BC3200 Mindray North America, Mahwah NJ USA).  186	  
To ensure consistency between laboratories for study one and study two, all antibody panels were first piloted 187	  
in Birmingham. For validation purposes, fluorescence-minus-one (FMO) tubes were used on separate samples from 188	  
three healthy donors to establish negative and positive gating strategies for all B cell surface markers. 189	  
 190	  
2.5 Statistical analyses 191	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 All results are presented as mean ± standard deviation unless otherwise stated. Statistical calculations were 192	  
performed on IBM SPSS for Windows Version 21. Kolmogorov-Smirnov tests were used to test for normally 193	  
distributed data. Repeated Measures Analysis of Variance (ANOVA) was used to contrast changes over time 194	  
(baseline, exercise and +30 min post-exercise for study one or +60 min post exercise for study two), with between 195	  
group factors used to assess differences between study one and two, where necessary. Post-hoc pairwise comparisons 196	  
between time-points were performed using Bonferroni adjustment for multiple comparisons. Between study 197	  
differences at a given time point (physiological data in Table 2) were assessed using one-way ANOVA. Statistical 198	  
significance was accepted at the p < .05 level.  199	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3. RESULTS 200	  
3.1 Physiological responses to exercise and workload measurements 201	  
All participants completed the exercise protocol in each study. Table 2 displays the summary data for power 202	  
output, workload, maximal heart rate during exercise, and maximal rating of perceived exertion. As expected, a 203	  
significant increase in all of these variables (p < .01) was observed during both exercise trials. Given that the trials 204	  
were not intensity-matched, the trials differed significantly in terms of power output and workload. As outlined in 205	  
Table 2, participants in study one reported a higher rating of perceived exertion compared to participants in study two, 206	  
whereas participants in study two exhibited a higher average power output and workload compared to participants in 207	  
study one. Participants in study two had a higher MAX compared with those taking part in study one. There were 208	  
no other significant differences between the participants taking part in each study, or for any other baseline parameters 209	  
measured. 210	  
 211	  
3.2 Effects of acute exercise on total lymphocytes and total B cells 212	  
Table 3 displays total lymphocyte numbers before, during and after each of the exercise trials. As expected, 213	  
total lymphocyte counts increased significantly during both exercise trials (p < .01), and we observed a greater 214	  
increase in total lymphocytes from baseline to the final minute of exercise for study one (+150%) compared to study 215	  
two (+80%) (F(2,14) = 13.1; p = .003). In the recovery period post-exercise, there were no significant decreases in total 216	  
lymphocyte number at 30 minutes (study one) or 60 minutes (study two) post-exercise compared to pre-exercise 217	  
values (p > 0.073). 218	  
The effects of each exercise trial on total B cell numbers is displayed in Table 3. In both studies, B cells 219	  
increased from baseline to the final minute of exercise. Despite differences in exercise intensity, we found no 220	  
differences between studies for the magnitude of total B cell mobilisation (p = NS). CD19+ B cells returned to resting 221	  
levels at 30 minutes post-exercise in study one. A marginal decrease in CD20+ B cells below resting levels was 222	  
observed at 60 minutes post-exercise in study two suggesting that B cells may leave the bloodstream to peripheral 223	  
sites post-exercise, as previously reported (8). 224	  
 225	  
3.3 Effects of acute exercise on B cell subsets  226	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 Table 3 shows the effects of each exercise trial on B cell subsets. All B cell subsets increased significantly 227	  
during exercise in study one (p < .01). The largest numerical contributors to the increase in CD19+ B cells were naïve 228	  
cells. However, there was an overall trend whereby immature B cells showed a greater proportional increase than 229	  
naïve and memory B cells (see Figure 1); though, these differences were not significant. Immature, naïve and memory 230	  
B cells returned to resting levels at 30 minutes post-exercise. Plasmablasts and purported ‘B1’ cells also increased 231	  
during exercise, and returned to resting levels at 30 min post-exercise (Table 3). Unlike study one, we did not observe 232	  
a significant increase across all B cell subsets during exercise in study two. Indeed, main effects of time were only 233	  
observed for immature and total memory B cells (p < .01); these cells returned to baseline levels at 60 minutes post-234	  
exercise. No significant increases were observed for class-switched IgA+ or IgG+ memory cells (p = NS). Like study 235	  
one, immature B cells appeared to be more sensitive to exercise than memory and naïve B cells (Figure 1). 236	  
To further elucidate whether immature B cells were more responsive to exercise than other B cell phenotypes 237	  
in each study, we compared the percentage change in immature cells with the percentage change in all other B cell 238	  
subsets, but no differences were observed (p = NS; data not illustrated). However, upon combining data from both 239	  
studies, an effect was found whereby immature cells were mobilised more than other B cell subsets (see Figure 2), 240	  
giving an indication that exercise may preferentially increase the number of immature cells over other B cell subsets 241	  
(F(1,30) = 4.9; p = .034). This approach is justified because cell surface CD10+ and IgD− expression on CD27− B cells 242	  
overlaps and broadly represents immature B cells (5, 30, 40). Using the same approach of combining other data from 243	  
the two exercise studies did not yield significant results for other B cell subsets, further supporting the finding that 244	  
immature B cells are most responsive to exercise stress. 245	  
4. DISCUSSION 246	  
This is the first study to document the effects of acute exercise on the mobilisation of a broad range of 247	  
phenotypically distinct B cell subsets. We found, in the two independent exercise trials reported in this study, that 248	  
immature B cells showed larger mobilisation responses than memory and naïve B cells.  249	  
To date, the phenotypic composition of B cell mobilisation during exercise has been poorly characterised. 250	  
This is despite numerous findings showing that total B cells increase two-fold during strenuous cycling (4), intensive 251	  
running (14), maximal rowing exercise (36), and after strenuous resistance exercise (31, 32). A similar effect is 252	  
observed during psychological stress (8). In the aforementioned stress study it was shown that CD62L− B cells are 253	  
preferentially mobilised, and, as CD62L is not expressed by antigen-experienced skin-homing B cells (17, 49), it was 254	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hypothesised that this finding represented the first step in the redirection of antigen-experienced B cells to peripheral 255	  
tissues. This is partly supported by our results where memory B cells appeared to increase more than naïve B cells, 256	  
albeit marginally. Despite these findings, the apparent larger mobilisation of immature B cells observed in our study 257	  
appears to contradict the hypothesis that effector B cells (i.e., with an antigen-experienced phenotype) are 258	  
preferentially mobilised by stress or exercise. Importantly, it has been shown that repeated exposure to acute stressors 259	  
appears to redirect B cells from the bone marrow to the spleen (13). It is suggested that the primary reason B cells 260	  
traffic to the spleen (i.e., the largest secondary lymphoid organ) after stress is to prepare for body injury and 261	  
subsequent pathogenic infection so that large numbers of naïve B cells are ‘on-site’ to efficiently screen for antigen 262	  
targets (13). The findings of our study may support this standing given that immature cells, which have yet to interact 263	  
with cognate antigen, were preferentially increased in the bloodstream for presumed later redistribution to secondary 264	  
lymphoid organs, where subsequent maturation and antigenic screening occurs.  265	  
In order to phenotype circulating B cells, each of the studies in this investigation used CD27 as a backbone 266	  
marker to distinguish between naïve and memory cells (29). It is clear however, that phenotyping memory B cells is 267	  
not straightforward, and these cells exhibit many levels of plasticity, and are likely comprised of a range of memory 268	  
subsets that may include T cell-dependent, T cell-independent, class-switched and class-unswitched phenotypes, 269	  
among others (28, 40). For this reason, further markers – in addition to CD27 – are needed to more precisely 270	  
characterise B cell subset responses to exercise. The challenges associated with B cell phenotyping in humans is 271	  
highlighted in the context of a population of purported ‘B1’ cells (21), which were also measured in the study herein. 272	  
‘B1’ cells are a population of B cells, originally identified in mice that produce high levels of low-affinity natural 273	  
antibody. In rats, it has been shown that natural IgM and B1 cells are increased in physically active versus sedentary 274	  
animals, but the effects of exercise in humans has remained unclear (11, 12). Recently, however, it has been shown 275	  
that the phenotypic markers proposed for purported human ‘B1’ cells are, in fact, a population of pre-plasmablasts in 276	  
humans (6). In agreement with the latter paper, we found that approximately 50% of ‘B1’ cells also expressed CD38 277	  
(data not shown) and thus likely represented a plasmablast phenotype (6). Finally, although the two exercise protocols 278	  
in this investigation led to significant changes in the percentages of circulating immature B-cells, it is important to 279	  
acknowledge that the absolute numbers of cells mobilised into peripheral blood remained modest. Future studies may 280	  
be able to provide insights on the biological significance of the exercise-induced changes in the immature B cell 281	  
compartment. 282	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A limitation of our study is that the intensity of exercise, or perhaps more substantially, the duration of 283	  
exercise, may have been insufficient to stimulate a large magnitude change in B cell numbers during and following 284	  
each trial. This idea is partly supported by the fact that study one – which resulted in a higher RPE and heart rate than 285	  
study two – mobilised total B cells to a greater extent. A dose-response relationship between exercise intensity and the 286	  
magnitude of lymphocytosis is well known (4, 22). It has also been established that the magnitude of exercise-induced 287	  
cortisol and catecholamine release, which have been implicated in maintaining lymphocytopenia (9), are strongly 288	  
influenced by exercise intensity and duration (15, 16, 22, 24). In the work presented herein, in the recovery period 289	  
following exercise (30 minutes in study one, and 60 minutes in study two) we did not observe a B cell 290	  
lymphocytopenia. Thus, it is likely that an exercise stimulus greater than the 20-30 minutes examined in the present 291	  
work would result in a more substantial post-exercise egress of cells from the bloodstream (15, 16, 22). Therefore, via 292	  
the implementation of more strenuous and prolonged exercise protocols, with a larger number of participants, future 293	  
studies may be able to better elucidate the phenotype of B cell subsets mobilised by exercise and those leaving the 294	  
bloodstream in the post-exercise period. A final consideration is that although it was our intention to employ different 295	  
exercise protocols and different cell phenotyping strategies between the two studies, study one undertook flow 296	  
cytometry analysis on PBMCs that had been cryopreserved, whereas study two undertook analyses on fresh PBMCs. 297	  
There is conflicting evidence to suggest that freezing and thawing cells can lead to a selective loss of certain 298	  
peripheral blood cell sub-types (19, 38). However, in this work we generally observed similar exercise-induced 299	  
patterns in B cell mobilisation between the two exercise studies. In addition, the viability of our cryopreserved cells 300	  
was >98% in all samples as shown by 7AAD exclusion (data not shown). Thus, it is unlikely that cryopreservation 301	  
affected the overall results. 302	  
 303	  
5. CONCLUSION 304	  
This investigation found, by employing two separate exercise protocols, and by using complimentary 305	  
phenotyping strategies, that exercise results in a mobilisation of B cells, of which the largest numerical contributors 306	  
were naïve cells. As expected, very few plasma cells and class switched IgG+ / IgA+ memory cells were present in the 307	  
peripheral blood, and did not appear to change substantially during exercise. Immature B cells showed that largest 308	  
magnitude of change in response to exercise, in both exercise trials, followed by memory B cells and naïve cells. 309	  
Thus, our findings show that, unlike T cells and NK cells (3, 4), B cell mobilisation is not driven by effector status, 310	  
13	  
	  
and, for the first time, that B cell mobilisation during exercise is partly comprised of immature CD27− IgD−/CD10+ 311	  
cells, which may aid in the screening of novel pathogens.   312	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FIGURE CAPTIONS 439	  
 440	  
Figure 1. Mean ± SEM percentage changes to B cell subset numbers, from baseline to immediately post-441	  
exercise, in study one (A) and study two (B). Within each trial, no significant differences were observed 442	  
between each subset. 443	  
 444	  
Figure 2. Mean ± SEM percentage changes from baseline to immediately post-exercise of immature B cell 445	  
subsets compared to all other B cells, from both exercise trials combined. * indicates significant difference 446	  
(p<0.05) observed between B cell subsets. 447	  
  448	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Table 1. B cell subset phenotypes characterised in study one and study two. 449	  
 450	  
 451	  
  452	  
B cell subset name 
 
Phenotype 
 Study one  
 B cells CD3−CD19+ 
 Immature B cells CD3−CD19+CD27−CD10+ 
 Naive B cells CD3−CD19+CD27−CD10− 
 Memory B cells CD3−CD19+CD27+CD38− 
 Plasmablasts / plasma cells CD3−CD19+CD27+CD38+ 
 ‘B1’ cells CD3−CD19+CD27+CD43+CD69− 
  
Study two 
 
 B cells 
Immature B cells 
CD20+ 
CD20+CD27−IgD− 
 Naïve B cells CD20+CD27−IgD+ 
 Memory B cells CD20+CD27+IgD− 
 IgA+ memory B cells CD20+CD27+IgA+ 
 IgG+ memory B cells CD20+CD27+IgG+ 
 IgM+ memory B cells CD20+CD27+IgM+ 
18	  
	  
Table 2. Exercise physiology data collected from participants enrolled in study one and study two. 453	  
 454	  
 Study 1 Study 2 
Average power output (Watts) 170.30 ± 33.27* 202.00 ± 62.00 
Average workload (Watts/kg) 2.18 ± 0.33* 2.87 ± 0.81 
Maximal heart rate (bpm) 187 ± 7 157 ± 11 
Maximal heart rate (%)a 94 ± 4 85 ± 6 
Rating of perceived exertion (Borg Scale) 18 ± 1 * 14 ± 1 
 455	  
* indicates significant difference between study one and study two (p < .05) 456	  
a calculated as a percentage of age predicted maximum using the equation: 191.5−0.007 × age2 (18).   457	  
 458	  
 459	  
	  460	  
  461	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Table 3.  Changes in the numbers (cells per µL) of B lymphocyte lineage cells in response to high intensity exercise 462	  
during study one (A) and study two (B). 463	  
A) Study one 
 
    
Cell type Phenotypic characterisation Baseline Exercise +30min Main effects of time 
Lymphocytes  1911.1 ± 410.6	   4833.3 ± 
1330.4**	  
1844.4 ± 353.9	   F(2,16) = 53.310; p < .001 
B cells CD3−CD19+ 161.8 ± 69.1	   304.2 ± 127.2**	   127.6 ± 38.4	   F(2,16) = 19.332; p = .001 
Immature B cells ‡ CD3−CD19+CD27−CD10+ 14.1 ± 8.7	   28.2 ± 12.8**	   11.5 ± 5.2	   F(2,16) = 21.615; p < .000	  
Naive B cells‡ CD3−CD19+CD27−CD10− 98.5 ± 47.2	   177.7 ± 80.4**	   73.6 ± 27.1	   F(2,16) = 17.923; p = .001	  
Memory B cells‡ CD3−CD19+CD27+CD38− 47.3 ± 23.1	   95.2 ± 55.4*	   41.0 ± 16.2	   F(2,16) = 11.967; p =.007	  
Plasmablasts / plasma cells‡ CD3−CD19+CD27+CD38+ 2.0 ± 1.9	   3.2 ± 2.2*	   1.5 ± 1.0	   F(2,16) = 10.465; p = .003	  
‘B1’ cells† CD3−CD19+CD27+CD43+CD69− 4.3 ± 2.0 7.9 ± 3.4* 3.7 ± 1.7 F(2,16) = 13.805; p = .002 
‡ estimated using the method of Caraux et al., 2010 464	  
† estimated using the method of Griffin et al., 2012 465	  
 466	  
B) Study two      
Cell type Phenotypic characterisation Baseline Exercise +60min Main effects of time 
Lymphocytes  1494.7 ± 643.4	   2697.1 ± 1104.7**	   1201.3 ± 473.6	   F(2,12) = 19.78; p = .004 
B cells CD20+   139.0 ± 86.3	   220.9 ± 129.4*	   120.8 ± 90.7*	   F(2,12) = 14.567; p = .004 
Immature B cells CD20+CD27−IgD− 7.6 ± 6.35	   15.3 ± 11.6	   5.9 ± 3.1	   F(2,10) = 5.19; p = .044	  
Naïve B cells CD20+CD27−IgD+ 89.6 ± 74.6	   130.1 ± 116.2	   84.1 ± 68.6	   F(2,10) = 4.84; p = .069 [NS]	  
Memory B cells CD20+CD27+IgD− 18.7 ± 11.2	   29.0 ± 15.9	   17.3 ± 12.9	   F(2,12) = 6.23; p = .023	  
IgA+ memory B cells CD20+CD27+IgA+ 1.8 ± 1.2	   2.6 ± 2.5	   1.9 ± 2.2	   F(2,12) = 0.073.; p = NS	  
IgG+ memory B cells CD20+CD27+IgG+ 7.6 ± 5.6	   11.6 ± 10.7	   6.0 ± 5.4	   F(2,12) = 0.073.; p = NS	  
IgM+ memory B cells CD20+CD27+IgM+ 0.6 ± 0.4	   0.7 ± 0.8	   0.4 ± 0.3	   F(2,12) = 1.814; p = NS	  
 467	  
*p < .05 in comparison to baseline  468	  
** p < .01 in comparison to baseline  469	  
NS p > .05 470	  
	  471	  
  472	  
20	  
	  
 473	  
 474	  
 475	  
 476	  
  477	  
A B 
21	  
	  
 478	  
 479	  
 480	  
 481	  
 482	  
 483	  
 484	  
	  485	  
 486	  
 487	  
	  488	  
 489	  
